Jazzminn Hembree Selected Research

Obesity

12/2012	Targeted estrogen delivery reverses the metabolic syndrome.
11/2012	Caloric restriction chronically impairs metabolic programming in mice.
10/2012	Role of adipose and hepatic atypical protein kinase C lambda (PKCλ) in the development of obesity and glucose intolerance.
6/2012	Restoration of leptin responsiveness in diet-induced obese mice using an optimized leptin analog in combination with exendin-4 or FGF21.
10/2009	A new glucagon and GLP-1 co-agonist eliminates obesity in rodents.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Jazzminn Hembree Research Topics

Disease

5	Obesity 12/2012 - 10/2009
2	Glucose Intolerance 10/2013 - 10/2012
2	Body Weight (Weight, Body) 10/2012 - 06/2012
1	Insulin Resistance 10/2013
1	Metabolic Syndrome (Dysmetabolic Syndrome X) 12/2012
1	Dyslipidemias (Dyslipidemia) 12/2012
1	Hyperglycemia 12/2012
1	Hyperphagia (Overeating) 11/2012
1	Weight Loss (Weight Reduction) 06/2012

Drug/Important Bio-Agent (IBA)

3	Insulin (Novolin)FDA Link 10/2013 - 10/2012
3	Peptides (Polypeptides)IBA 12/2012 - 10/2009
2	Hormones (Hormone)IBA 12/2012 - 06/2012
2	Glucagon-Like Peptide 1 (GLP 1)IBA 12/2012 - 10/2009
2	Glucose (Dextrose)FDA LinkGeneric 11/2012 - 10/2012
1	IncretinsIBA 10/2013
1	Estrogens (Estrogen)FDA Link 12/2012
1	LipidsIBA 11/2012
1	protein kinase C lambdaIBA 10/2012
1	fibroblast growth factor 21IBA 06/2012
1	Islet Amyloid PolypeptideIBA 06/2012
1	LeptinIBA 06/2012
1	Exenatide (Byetta)FDA Link 06/2012
1	Glucagon (Glukagon)FDA Link 10/2009
1	Glucagon Receptors (Glucagon Receptor)IBA 10/2009

Therapy/Procedure

4	Therapeutics 12/2012 - 06/2012
2	Caloric Restriction 11/2012 - 06/2012